![Jenni Ilomaki Profile](https://pbs.twimg.com/profile_images/1060670338038554624/2wbMQJbS_x96.jpg)
Jenni Ilomaki
@jenni_ilomaki
Followers
261
Following
1K
Statuses
446
Associate Professor, Pharmacoepidemiology
Melbourne, Victoria
Joined April 2018
New publication from our PhD candidate @Miriam_TY_Leung on gabapentinoids and hip fractures risk. @CentMedUseSafet @OptimisingRxUse @claremarquina @TimTran21
1
9
16
Great presentations by @CentMedUseSafet PhD candidates @_GeorgeTan, @KimStellajh and @Miriam_TY_Leung in Berlin! #icpe2024 @IntPharmacoEpi @MIPS_Australia
0
6
24
@rebeccahritchie @AbhipreeSharma @MilesDeBlasio @MIPS_Australia @HRM_MIPS @ECI_ISHR Congratulations Abhi! 🥳
0
0
3
@KilkennyMonique @MonashUni @SCSMonash @MonashVHI @DominiqueCad @EricFMorand @TheFlorey @strokefdn @heartfoundation @nhmrc Congrats Monique 🥂
0
0
0
@alene_yong @CentMedUseSafet @DementiaAus @AmandaJCross Congratulations Alene on your first Melbourne run 🏃 . Well done! @CentMedUseSafet @MIPS_Australia @DementiaAus
0
0
4
RT @ZANFINA: A follow up paper by @tamrat_ab2012 “impact on health outcomes of ischeamic stroke, 20 years projections using linked data. @…
0
5
0
RT @ZANFINA: Great work from PhD student @tamrat_ab2012 for showing impact of current and future burden of #stroke in Australian healthcare…
0
8
0
RT @cardiopharmnerd: New study investigating medication use following heart attack in nearly 30,000 admissions in Victoria. Hannah demonst…
0
4
0
RT @_GeorgeTan: Outcome-wide cohort study design to identify novel collateral benefits and new indications of SGLT-2 inhibitor Check out t…
0
4
0
@KateNWang @RMITPharmacy @TeachPharm @ThrimawithanaT @AmyTPage @KennyPharmPhD @JS1989Park @edwincktan @DrJuliaGT Congratulations Kate 🎉
0
0
1
RT @GrampiansHealth: Does being further away from a capital city have an impact after a heart attack? Grampians Health researcher Adam Livo…
0
4
0
RT @LouiseCLord: More promising implications of modulator therapy @CFAustralia @cftrust @CF_Foundation @CFNewsToday #cysticfibrosis
0
3
0